Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Leucine-rich repeat and coiled-coil centrosomal protein 1 (LRRCC1) is a centrosomal protein essential for the organization and maintenance of the structural integrity of centrosomes during mitosis. It contains an N-terminal leucine-rich repeat domain and a C-terminal coiled-coil domain and accumulates at the centrosome throughout the cell cycle, particularly during mitosis, where it is required for proper mitotic spindle formation[1][2][3][7]. There is no current evidence that LRRCC1 is directly targeted by any drugs, nor is it classified as an enzyme, receptor, transporter, or channel. Defects in LRRCC1 have been associated with certain developmental syndromes, reflecting its fundamental role in cell division[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Leucine-rich repeat and coiled-coil centrosomal protein 1 (LRRCC1).